Live feed
Filing
SC 13G
SC 13G0001019231-21-000010·Taysha Gene Therapies, Inc.
Schedule 13G ownership disclosure
Taysha Gene Therapies Inc
Security class unavailable · CUSIP: 877619106
Event date: 2021-09-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,156,255
- Percent of class
- 3.0100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019231-21-000010
- Form type
- SC 13G
- Filer
- Taysha Gene Therapies, Inc.
- CIK
- CIK 1806310
- Filed
- Sep 24, 2021
- Reporting period
- Sep 22, 2021
- Description
- Schedule 13G beneficial ownership